Next report date
Report period
Q1 2024
EPS estimate
0.01USD
Revenue estimate
375.52 MUSD
−535.98 MUSD
1.24 BUSD
88.87 M
Om Sarepta Therapeutics, Inc.
Sektor
Bransch
VD
Douglas S. Ingram
Webbplats
Huvudkvarter
Cambridge
Employees (FY)
1.31 K
Grundat
1980
FIGI
BBG00JVXHBD4
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
